Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance

For the three months and full year ended December 31, 2023: Revenues of $775.4 million for the fourth quarter, $3,109.0 million for the full yearGAAP net loss of $ million for the fourth quarter, $...

Related Keywords

United States ,Tom Pike ,Exchange Commission ,Globenewswire Inc ,Company Registration Statement On Form ,Fortrea Holdings Inc ,Clinical Services ,Linkedin ,Laboratory Corporation Of America Holdings Labcorp ,Company The ,Revenue For Clinical Services ,Securities Exchange ,Patient Access ,Earnings Call ,Endpoint Clinical ,Fortrea Patient Access ,Fortrea Investor Relations ,Securities Act ,Securities Exchange Act ,Laboratory Corporation ,America Holdings ,Information Statement ,Registration Statement ,Adjusted Net Income ,Adjusted Basic ,Free Cash ,Enabling Services ,